Ackman defends Valeant, hints at more changes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/5/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Netflix raises prices in Germany and Austria, Citi comments
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Valeant Pharma (VRX) Continues Push Higher
May 3, 2016 12:44 PM EDTValeant Pharma (NYSE: VRX) is pushing to the highs of the session following positive credit rating agency comments on a default, strong results from peer Mallinckrodt, short covering and as Joe Papa officially assumes the reigns.
Shares are up 9.85% to $35.87.
... MoreGeneral Growth Properties (GGP) Declares $0.19 Quarterly Dividend; 2.7% Yield
May 3, 2016 8:50 AM EDTGeneral Growth Properties (NYSE: GGP) declared a quarterly dividend of $0.19 per share, or $0.76 annualized.
The dividend will be payable on July 29, 2016, to stockholders of record on July 15, 2016, with an ex-dividend date of July 13, 2016.
The annual yield on the dividend is 2.7... More
Valeant Pharma (VRX) Says Joseph Papa Officially Assumes Role of Chairman, CEO
May 3, 2016 7:15 AM EDTValeant Pharmaceuticals International, Inc. (NYSE: VRX) announced that Joseph C. Papa has assumed the role of Chairman and Chief Executive Officer. As previously announced, Joseph C. Papa succeeds J. Michael Pearson.
"I am thrilled to begin working closely with the talented... More
Valeant Pharma (VRX) may change its name at some point - Bill Ackman
May 2, 2016 12:43 PM EDTValeant Pharma (NYSE: VRX) may change its name at some point - Bill Ackman
... More